Abstract
A method of diagnosing and/or prognosing an abnormality, such as a proliferative disorder in a subject, includes performing an IR spectroscopic analysis of a wet biofluid sample, such as a blood sample (or component thereof) from the subject; to produce a spectroscopic signature characteristic of the biofluid/blood sample (or component thereof).
| Original language | English |
|---|---|
| Patent number | WO2017221027A1 |
| IPC | A61B5/00,G01N33/68 |
| Priority date | 24/04/16 |
| Filing date | 23/06/17 |
| Publication status | Published - 28 Dec 2017 |
Keywords
- infrared spectroscopy
- analysis of bodily fluids
- cancer diagnosis
- IR spectroscopic analysis
- wet biofluid sample